INTEGRA Biosciences Nordic ApS: Financial statements 2023
CVR: 43279092
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
INTEGRA Biosciences Nordic ApS (CVR 43279092) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,905,351 and a net result of DKK -956,194. Equity in the 2023 report amounted to DKK -1,949,578. The company had 4 employees in the financial year.
- Gross Profit
- DKK 2,905,351
- Profit/Loss
- DKK -956,194
- Equity
- DKK -1,949,578
- Total Assets
- DKK 8,624,226
- Employees
- 4
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
INTEGRA Biosciences Nordic ApS has published its interim report for the period May 18, 2022 to December 31, 2022.
About INTEGRA Biosciences Nordic ApS
INTEGRA Biosciences Nordic ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2022. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Kirsten Thuesen, Sven Karl Linder and Torbjørn Gripp. The company is owned by INTEGRA Biosciences Holding AG. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 7,117,285 and a net result of DKK 413,813 compared with DKK -1,699,859 the year before. Equity in the 2025 report amounted to DKK -3,235,625.